Jacqueline Cloos is full professor Translational Hematology, in particular acute leukemia at the Amsterdam UMC, location VUMC since April 2018. She is head of the MRD team, which performs MRD measurements of the AML HOVON studies and several additional clinical AML studies investigating novel drugs. This entails about 2000 samples each year from >50 institutes around the world. She is chairperson of the Dutch AML MRD working party and active member of the European Leukemia Net AML MRD working group. Her research interests include clonal evolution, drug resistance mechanisms and novel targets of therapy such as splicing and proteasomes.